Search Results

Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's Adverse Event Reporting System dataset.

• Authors : Salah S; La Roche-Posay Laboratoire Dermatologique, Levallois Perret, France. Electronic address: .; Kerob D

Subjects: Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; United States Food and Drug Administration* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects

• Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Nov; Vol. 91 (5), pp. 863-871. Date of Electronic Publication: 2024 Jul 20.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists.

• Authors : Ituarte BE; Taylor MA; Thomas SI

Subjects: United States Food and Drug Administration*; Humans ; United States/United States/United States/epidemiology

• Source: Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2024 Sep 01; Vol. 23 (9), pp. e181-e182.Publisher: Physicians Continuing Education Corporation Country of Publication: United States NLM ID: 101160020 Publication Model:

Record details

Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets

• Authors : Shah, Pranali N.; Romar, George A.; Manukyan, Artur

• Source: Journal of Clinical Investigation. September, 2024, Vol. 134 Issue 17

Record details

Severe cutaneous adverse reactions associated with immune checkpoint inhibitors therapy and anti-VEGF combination therapy: a real-world study of the FDA adverse event reporting system.

• Authors : Li C; Department of Pharmacy, Qilu Hospital of Shandong University, Jinan, China.; Li Z

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/administration & dosage ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data

• Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Jun; Vol. 23 (6), pp. 777-784. Date of Electronic Publication: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab Vedotin.

• Authors : Vlachou E; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD.; Mamtani R

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; White People*/White People*/White People*/statistics & numerical data

• Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Jun; Vol. 22 (3), pp. 102090. Date of Electronic Publication: 2024 Apr 07.Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium:

Record details

Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.

• Authors : Godfrey H; University of Arizona College of Medicine-Tucson, Tucson, Arizona, USA.; Jedlowski P

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; United States Food and Drug Administration*

• Source: The Australasian journal of dermatology [Australas J Dermatol] 2024 May; Vol. 65 (3), pp. 243-253. Date of Electronic Publication: 2024 Apr 04.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0135232 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Supportive oncodermatology practices in Europe and the USA.

• Authors : Freites-Martinez A; Oncodermatology Clinic, Hospital Ruber Juan Bravo and Universidad Europea, Madrid, Spain.; Apalla Z

Subjects: Dermatology*; United States ; Europe

• Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 May; Vol. 38 (5), pp. e440-e443. Date of Electronic Publication: 2023 DecPublisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Lyme Disease: An Overview.

• Authors : Mahajan, Vikram K.

Subjects: LYME disease; TICK-borne diseases; BORRELIA burgdorferiUNITED States

• Source: Indian Dermatology Online Journal; Sep/Oct2023, Vol. 14 Issue 5, p594-604, 11p

Record details

Drug patch testing for severe cutaneous adverse reactions: Not in the United States?

• Authors : Whitley L; Los Alamos Medical Care Clinic Ltd, Los Alamos, New Mexico; Department of Clinical Medicine, Burrell College of Osteopathic Medicine, Las Cruces, New Mexico.

Subjects: Skin* ; Drug Eruptions*; Humans

• Source: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2023 May; Vol. 130 (5), pp. 538-539.Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication

Record details

Pharmacist-led improvement in perioperative antibiotic selection for patients with a penicillin allergy label.

• Authors : Stonerock, Devon¹ ; Hallo-Carrasco, Alejandro²; Edwards, Michael³

Subjects: *ANTIBIOTICS; *PERIOPERATIVE care; *ANTIMICROBIAL stewardshipUNITED States

• Source: American Journal of Health-System Pharmacy. May2023, Vol. 80 Issue 9, pe111-e118. 8p. 1 Diagram, 2 Charts.

Record details